Public trackerCorpus refreshed Aug 15, 2026 · Latest decision Aug 11, 2026Public incidents are risk signals, not usage-adjusted rates
HomeCasesIn re: Philips Recalled CPAP, Bi-Level PAP, and Mechanical Ventilator Products Liability Litigation (Gravelyn)
Evidence review: primary document verified. The linked primary document was extracted and checked with page-level evidence locators.
Evidence-linked corpus record: this page is generated from the structured public record and has a publication-readiness score of 90/100. It passes the current publication gate; that is not a legal-editorial review or a guarantee that every field has been independently verified.
Corpus matter record

In re: Philips Recalled CPAP, Bi-Level PAP, and Mechanical Ventilator Products Liability Litigation (Gravelyn)

J.P.M.L. · Apr 6, 2026

Direct answer

What happened in this matter?

The J.P.M.L. issued a formal admonishment to the plaintiff and counsel for submitting a brief containing fabricated and misrepresented legal authorities. The Panel warned that such conduct constitutes an abuse of the judicial process and that future non-compliant filings may be stricken or subject to additional corrective measures.

Why the court cared
The Panel reasoned that the plaintiff's citations were inaccurate and misrepresented the holdings of the underlying cases, constituting an abuse of the judicial process that requires admonishment to maintain the integrity of the record.
Why it matters now
Verify reporter citations in JPML briefs; wrong reporters expose misrepresentation even when the case name is real.

Why this matter is tracked

In a transfer order regarding MDL No. 3014, the Judicial Panel on Multidistrict Litigation (J.P.M.L.) addressed a motion to vacate the conditional transfer of the Gravelyn action. The Panel granted the transfer, finding that the action shared common factual questions with the existing MDL. During its review, the Panel identified that the plaintiff’s brief contained multiple inaccurate citations and misrepresented the holdings of cited cases, including In re Xarelto and In re Eliquis. The Panel explicitly admonished the plaintiff and counsel for submitting false legal representations, noting that the nature of the errors suggested the potential use of generative AI without independent verification. The Panel warned that future non-compliant submissions could result in the striking of filings or further corrective action.

Operational lesson

Verify reporter citations in JPML briefs; wrong reporters expose misrepresentation even when the case name is real.

Record details

CourtJ.P.M.L.
Jurisdictionfederal
CircuitNot recorded
DateApr 6, 2026
GE
AI toolGenerative artificial intelligence (unspecified)
Party typeLawyer
OutcomeThe motion to vacate was denied, the action was transferred to the Western District of Pennsylvania, and the plaintiff and counsel were formally admonished for misrepresenting legal authorities.
Known amountNot recorded
Professional sanctionFormal judicial admonishment for fabricating and misrepresenting legal authorities.
Attribution boundary

What the record establishes about AI use

implied

The Panel noted the nature of the errors suggested the use of generative AI.

Procedural posture

Transfer order issued by the J.P.M.L. following a motion to vacate a conditional transfer order.

Correction behavior

Correction behavior is not separately verified in the current record.

Tracked discrepancy record

4 citation, quotation, or authority issues are recorded in the source dataset.

  1. Misrepresented: Case Law | Plaintiff cited Xarelto as In re Xarelto (Rivaroxaban) Prods. Liab. Litig., 223 F. Supp. 3d 1348, 1349 (J.P.M.L. 2016); the reporter citation provided is incorrect/for a different MDL and the holding was misrepresented.
  2. Misrepresented: Case Law | Plaintiff cited Eliquis (Apixaban) as supporting denial of transfer though the Panel in Eliquis created an MDL and transferred the actions; the holding was misrepresented.
  3. Misrepresented: Case Law | Plaintiff cited In re Bard IVC Filters, 2016 WL 5867451 (J.P.M.L. Oct. 5, 2016), but that citation points to a Southern District of New York decision rather than a J.P.M.L. decision; authority misrepresented/miscited.
  4. Misrepresented: Case Law | Plaintiff cited In re Vioxx, 478 F. Supp. 2d 1376 (J.P.M.L. 2007), but that citation leads to a Northern District of Georgia decision rather than the Panel decision cited; miscitation/misrepresentation.

Questions this record answers

What happened in In re: Philips Recalled CPAP, Bi-Level PAP, and Mechanical Ventilator Products Liability Litigation (Gravelyn)?
The J.P.M.L. issued a formal admonishment to the plaintiff and counsel for submitting a brief containing fabricated and misrepresented legal authorities. The Panel warned that such conduct constitutes an abuse of the judicial process and that future non-compliant filings may be stricken or subject to additional corrective measures.
Why does In re: Philips Recalled CPAP, Bi-Level PAP, and Mechanical Ventilator Products Liability Litigation (Gravelyn) matter for legal AI risk?
Verify reporter citations in JPML briefs; wrong reporters expose misrepresentation even when the case name is real.
What does the public record establish about In re: Philips Recalled CPAP, Bi-Level PAP, and Mechanical Ventilator Products Liability Litigation (Gravelyn)?
The record summarizes the outcome described in the linked public source. The recorded document is hosted in the upstream publisher archive. This page is not a substitute for the complete docket, subsequent history, or jurisdiction-specific advice.
Which source supports this In re: Philips Recalled CPAP, Bi-Level PAP, and Mechanical Ventilator Products Liability Litigation (Gravelyn) summary?
The recorded source is Damien Charlotin case archive. It is classified as publisher document archive; review the linked material and subsequent docket history before relying on this summary.

Related matters

Related by court, jurisdiction, tool, or classified failure pattern. Similarity does not imply the same facts or outcome.